Helvacı, N. Et Al. 2019. Clinical significance of soluble DCR3 in breast cancer patients before and after radiotherapy. XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019XXX. National Congress of the Turkish Biochemical Society TBS 2019 , 76.

Helvacı, N., KILIÇ, E., YILDIZ, O. G., & BAŞKOL, G., (2019). Clinical significance of soluble DCR3 in breast cancer patients before and after radiotherapy . XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019XXX. National Congress of the Turkish Biochemical Society TBS 2019 (pp.76).

Helvacı, Nazlı Et Al. "Clinical significance of soluble DCR3 in breast cancer patients before and after radiotherapy," XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019XXX. National Congress of the Turkish Biochemical Society TBS 2019, 2019

Helvacı, Nazlı Et Al. "Clinical significance of soluble DCR3 in breast cancer patients before and after radiotherapy." XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019XXX. National Congress of the Turkish Biochemical Society TBS 2019 , pp.76, 2019

Helvacı, N. Et Al. (2019) . "Clinical significance of soluble DCR3 in breast cancer patients before and after radiotherapy." XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019XXX. National Congress of the Turkish Biochemical Society TBS 2019 , p.76.

@conferencepaper{conferencepaper, author={Nazlı Helvacı Et Al. }, title={Clinical significance of soluble DCR3 in breast cancer patients before and after radiotherapy}, congress name={XXVII. Balkan Clinical Laboratory Federation Meeting BCLF 2019XXX. National Congress of the Turkish Biochemical Society TBS 2019}, city={}, country={}, year={2019}, pages={76} }